Literature DB >> 27745630

Interleukin-12 immunohistochemistry as a diagnostic tool for patch-stage mycosis fungoides.

David M Lemchak1, Oleg E Akilov2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27745630      PMCID: PMC5501930          DOI: 10.1016/j.jaad.2016.06.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Expression of T-bet and GATA-3 in early mycosis fungoides and spongiotic dermatitis.

Authors:  Amira Elbendary; Kruti Parikh; Inas Elattar; Jonathan Truong; Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2016-05       Impact factor: 11.527

2.  Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.

Authors:  Sean D Doherty; Xiao Ni; Christy B Doherty; Dan Jones; Xing Zhao; Laurie B Owen; Madeleine Duvic
Journal:  Arch Dermatol Res       Date:  2006-09-26       Impact factor: 3.017

3.  Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.

Authors:  Andy C Hsi; Sena J Lee; Ilana S Rosman; Kenneth R Carson; Amanda Kelley; Valerie Viele; Xiaofan Pang; Amy Musiek; András Schaffer
Journal:  J Am Acad Dermatol       Date:  2014-10-18       Impact factor: 11.527

Review 4.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

5.  Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.

Authors:  G Saed; D P Fivenson; Y Naidu; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1994-07       Impact factor: 8.551

  5 in total
  1 in total

Review 1.  Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL).

Authors:  Karol Kołkowski; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.